MRNS
Marinus Pharmaceuticals Inc
Price:  
9.99 
USD
Volume:  
275,969.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS Relative Valuation

-401.0%
Upside

As of 2024-02-27, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (30.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.99 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -401.0%.

The range of the Relative Valuation is (23.12) - (30.53) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 9.2x - 12.4x 11.0x
Forward P/E multiples 9.4x - 14.0x 13.5x
Fair Price (23.12) - (30.53) (30.07)
Upside -331.4% - -405.6% -401.0%
9.99 USD
Stock Price
(30.07) USD
Fair Price

MRNS Relative Valuation - Historical P/E Data

Date P/E
2024-02-26 -4.07
2024-02-23 -3.98
2024-02-22 -3.92
2024-02-21 -3.97
2024-02-20 -3.89
2024-02-16 -4.06
2024-02-15 -4.07
2024-02-14 -4.08
2024-02-13 -4.03
2024-02-12 -4.16
2024-02-09 -4.11
2024-02-08 -4.07
2024-02-07 -4.04
2024-02-06 -4.07
2024-02-05 -4.05
2024-02-02 -4.07
2024-02-01 -4.07
2024-01-31 -3.97
2024-01-30 -4.07
2024-01-29 -4.14
2024-01-26 -4.08
2024-01-25 -4.07
2024-01-24 -4.02
2024-01-23 -4.05
2024-01-22 -4.12
2024-01-19 -3.92
2024-01-18 -3.97
2024-01-17 -3.92
2024-01-16 -3.88
2024-01-12 -3.99
2024-01-11 -4.18
2024-01-10 -4.28
2024-01-09 -4.48
2024-01-08 -4.57
2024-01-05 -4.42
2024-01-04 -4.29
2024-01-03 -4.25
2024-01-02 -4.24
2023-12-29 -4.43
2023-12-28 -4.48
2023-12-27 -4.47
2023-12-26 -4.40
2023-12-22 -4.25
2023-12-21 -3.96
2023-12-20 -3.78
2023-12-19 -3.85
2023-12-18 -3.65
2023-12-15 -3.50
2023-12-14 -3.54
2023-12-13 -3.59